Skip to main content
RAPS Convergence 2023 Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Requires Pre-Registration or Sign-up
Requires Pre-Registration or Sign-up
Additional Registration Fee
Additional Registration Fee
Invitation Only
Invitation Only
Student Program
Student Program
Networking Opportunity
Networking Opportunity
RAPS Focus Area
RAPS Focus Area
Back

Kelly Robinson

Director General, Marketed Health Products Directorate
Health Canada

Kelly Robinson is the Director General of Health Canada’s Marketed Health Products Directorate. In this capacity, she works with a multidisciplinary team on a range of post-market regulatory activities for health products, including adverse event surveillance, assessment and risk mitigation, risk communications, advertising monitoring, policy development, use of real-world evidence and domestic and international stakeholder engagement.

Kelly has extensive pre- and post-market regulatory experience with Health Canada, and has been involved in the review and authorization of pharmaceuticals and biologics for more than 20 years. She has played a leadership role in initiatives such as aligning reviews between Health Canada and Health Technology Assessment organizations, international work-sharing, and collaboration with foreign regulatory authorities.

Disclosure information not submitted.

Presentation(s):